Congress Had a Chance to Make Your Drugs Traceable. They Didn’t Follow Through
A bipartisan bill promised greater transparency into where prescription drugs are manufactured. Then a key provision was removed
Oct 13, 2026
Rosemary Gibson is author of China Rx: Exposing the Risks of America’s Dependence on China for Medicine. She received the highest honor from American Medical Writers Association for outstanding contributions to reporting on critical health issues in the public interest.
She served on the Defense Health Board Health Care Delivery Subcommittee. She was board chair at Altarum, board member of the Accreditation Council for Graduate Medical Education and served on the CLER Evaluation Committee to advance patient safety in teaching hospitals.
Her books – Wall of Silence, Treatment Trap, Battle Over Health Care, Medicare Meltdown – have been reviewed in Publishers Weekly, Washington Post, JAMA, Health Affairs; referenced in proceedings of the U.S. Senate; mentioned in Congressional testimony; noted in WSJ, NYT, USA Today, Consumer Reports, and Boston Globe, O Magazine, Reader’s Digest, US News and World Report, & Modern Healthcare. Wall of Silence was translated into Japanese; the Chinese translation of Treatment Trap won the prestigious Open Book Award from China Times. Rosemary has appeared on Chicago Tonight, WBGH’s Greater Boston, The Doctors, C-Span Book TV.
A bipartisan bill promised greater transparency into where prescription drugs are manufactured. Then a key provision was removed
Oct 13, 2026We think it’s invaluable — and hope you agree. Our work is made possible by donations from readers like you.
We think it’s invaluable — and hope you agree. Our journalism is made possible by donations from readers like you.
As a nonprofit, we don’t take a dime from pharmaceutical or supplement companies. That means we can report on the benefits, risks, and alternatives to prescription and over-the-counter drugs free from corporate pressure or influence.